Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Codeine/Guaifenesin ER vs IR in Healthy Subjects
NCT02572375Phase 1Completed
- Sponsor
- Nexgen Pharma
- Start
- Oct 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of codeine and guaifenesin in cough (2 arms), sponsored by Nexgen Pharma. Primary endpoints: Peak Plasma Concentration at 1 week and Area under the plasma concentration versus time curve at 1 week. Started Oct 2014; status: completed.
02
Drugs
codeineguaifenesin
03
Conditions
cough
Beyond the preview
Go deeper on NCT02572375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572375.